Is Revvity, Inc. (RVTY) Fairly Valued?
Revvity, Inc. valuation review using P/E, fair value, revenue growth, EPS growth, net margin, and TGMCharts chart exhibits as of July 8, 2026.
By TGMCharts Research · Data as of · Updated
Revvity, Inc. presents a multi-layered valuation profile where the trailing P/E of 52.07x is elevated relative to the analyst DCF (FMP) reference of $101, meaning market expectations must be evaluated against actual business expansion.
The core evidence rests on contrasting growth and profitability metrics against pricing multiples. While five-year revenue CAGR stands at -8.12% and five-year EPS CAGR is -20.48%, the company maintains a net margin of 8.30% to support its current multiple.
- Revvity, Inc. closed at $113 on July 8, 2026.
- Trailing P/E is 52.07x and price-to-sales is 4.21x.
- Analyst DCF (FMP) is $101 with margin of safety at -7.29%.
- Five-year revenue CAGR is -8.12% and five-year EPS CAGR is -20.48%.
- Earnings yield is 1.92% and net margin is 8.30%.
Valuation Setup
The market price, model anchor, growth support, and profitability facts behind the valuation read.
Evaluating the Pricing Premium and Business Support
Analyzing Revvity, Inc. requires evaluating whether the current market valuation is backed by sufficient financial performance. With the stock closing at $113 on July 8, 2026, equity markets have priced the shares at 52.07x trailing earnings. This multiple sits above the independent analyst-DCF (FMP) reference of $101, which translates to a negative margin of safety of -7.29%.
To determine if this valuation is sustainable, we must look beyond a single ratio. This analysis examines P/E, sales multiples, earnings yield, historical revenue and EPS growth trends, and net margins to assess whether the underlying business fundamentals justify the premium.
Market Pricing and Multiple Framework
The market currently prices the business at a price-to-sales ratio of 4.21x, reflecting the premium paid for top-line revenue. This pricing structure yields an earnings yield of 1.92%, which represents the cash flow return generated per dollar of market value. Evaluating these metrics together helps determine if the multiple is supported by structural business value or if it is primarily driven by expanding valuation multiples.
RVTY P/E ratio Chart
The trailing earnings multiple is the main valuation exhibit because it connects the market price to reported earnings.
Latest P/E ratio: 52.07x as of July 8, 2026.
A P/E ratio of 52.07x has to be judged against the company's five-year EPS CAGR of -20.48%. If the multiple is high while EPS support is ordinary, the valuation thesis becomes more dependent on investor confidence than on fresh earnings power.
RVTY price-to-sales Chart
Price-to-sales gives a second valuation lens when margins and earnings can move around the cycle.
Latest price-to-sales ratio: 4.21x.
Price-to-sales at 4.21x is most useful beside net margin of 8.30%. A richer sales multiple is easier to defend when margin quality is durable rather than temporarily elevated.
Discount and Premium Relative to Analyst DCF
The independent analyst DCF (FMP) model establishes a reference price of $101, positioning the market price of $113 above this benchmark. The resulting margin of safety is -7.29%. This external calculation is a useful comparison point, but it should be weighed alongside the broader scenario ranges detailed on the TGMCharts valuation platform.
The valuation at a glance
Each input on its own line: what the stock costs against earnings and sales, the model's fair value and how far price sits from it, and the growth and margins behind the business.
RVTY earnings yield Chart
Earnings yield reframes valuation from an owner's-yield perspective rather than a multiple perspective.
Latest earnings yield: 1.92%.
The earnings yield of 1.92% is the counterweight to the P/E ratio. If the yield is thin relative to the quality and growth profile, the valuation case needs more help from future compounding.
Long-Term Growth Trends and Multiple Sustainability
Over the past five years, top-line and bottom-line trends have diverged. The five-year revenue CAGR is -8.12%, while the five-year EPS CAGR stands at -20.48%. Although trailing twelve-month revenue has shown positive growth, trailing twelve-month EPS, net income, and free cash flow have all declined. This divergence indicates that the current P/E multiple is supported more by valuation expansion than by long-term earnings growth.
RVTY revenue
Revenue history tests whether the valuation is being supported by real business expansion.
Five-year revenue CAGR: -8.12%. This is endpoint-to-endpoint from the fiscal years shown — a depressed start year can inflate it, so read it against the recent bars.
Revenue growth is the business-expansion evidence behind the valuation read. A five-year revenue CAGR of -8.12% helps show how much of the valuation story is coming from company growth instead of only multiple expansion.
RVTY EPS
EPS history checks whether reported earnings are keeping pace with the market multiple.
Five-year EPS CAGR: -20.48%. This is endpoint-to-endpoint from the fiscal years shown — a depressed or negative start year can inflate it, so read it against the recent bars.
A five-year EPS CAGR of -20.48% is the clearest support figure for a P/E-based conclusion. If EPS growth slows while the multiple remains elevated, the article should become more cautious after refresh.
Profitability Quality and Sales Multiples
Profitability margins help determine whether a high sales multiple is sustainable. The company currently generates a net margin of 8.30% alongside its price-to-sales ratio of 4.21x. When sales multiples are elevated, profit margins must remain stable or expand to prevent earnings dilution. If margins face pressure, the premium valuation becomes more vulnerable to market corrections.
RVTY net margin
Net margin shows whether the company has enough profitability quality to support its valuation.
Net margin (TTM): 8.30%. The bars below are annual fiscal years.
Net margin of 8.30% is a quality signal, not a valuation verdict by itself. It matters because a premium multiple is more defensible when margins are structurally strong and less defensible when margins are peaking.
The Core Arguments for and Against the Current Valuation
The optimistic view relies on the company's positive short-term revenue growth and its net margin of 8.30% to support its market position. Conversely, the cautious view highlights that the stock trades above its analyst-DCF reference, while trailing earnings, net income, and free cash flow are declining. This suggests the market may be overestimating future growth prospects.
Bull and bear case
Valuation support
- Five-year revenue CAGR of -8.12% and five-year EPS CAGR of -20.48% support the business case.
- Net margin of 8.30% is the quality check behind the multiple.
Valuation pressure
- A P/E ratio of 52.07x can become demanding if EPS growth slows.
- The analyst-DCF (FMP) margin of safety at -7.29% should change the valuation read if it deteriorates after refresh.
Key Metrics to Monitor for a Shift in Outlook
Several factors could alter this valuation perspective. A major shift in the stock price toward or away from the analyst-DCF reference of $101 would directly impact the margin of safety. Additionally, any stabilization or further decline in the five-year EPS CAGR of -20.48%, or a change in the net margin from its current level of 8.30%, would require a reassessment of the stock's valuation.
Synthesis of the Valuation Profile
In conclusion, the valuation of Revvity, Inc. depends on whether its operational efficiency can offset declining trailing earnings and cash flows. With the market price exceeding the analyst-DCF benchmark, the business must improve its bottom-line performance to support its current multiples. This analysis is based on historical financial filings and does not constitute personalized investment advice.
FAQ
Is RVTY fairly valued?
Revvity, Inc. trades at 52.07x trailing earnings with an analyst-DCF (FMP) margin of safety of -7.29%. The cleanest read comes from comparing that valuation to five-year revenue CAGR of -8.12% and five-year EPS CAGR of -20.48%.
What valuation metric matters most for RVTY?
This article anchors on P/E, fair value, margin of safety, price-to-sales, earnings yield, revenue growth, and EPS growth. No single metric is treated as a recommendation.
How often should this RVTY valuation view refresh?
We refresh this note after each daily market close, so the price, fair value, and every figure stay current. Numbers here are as of July 8, 2026.
What would change our mind
- A material move away from the analyst-DCF (FMP) reference of $101.
- A break in five-year EPS support, currently -20.48%.
- Margin quality drifting away from the latest net margin of 8.30%.
The bottom line
Revvity, Inc. valuation research note from TGMCharts Research, grounded in precomputed fundamentals, chart exhibits, and a frozen claim ledger.
Read next: RVTY fundamentalsContinue with Revvity, Inc.'s full stock page.How we checked this researchShowHide
Data snapshot · By TGMCharts Research.
Every number in this note comes from data we compute and store ourselves from the company's reported figures, plus verbatim excerpts from its SEC filings. When a value isn't available we say so — we never fill gaps with estimates.
Latest filing excerpt
10-Q · filed 2026-05-12 · period 2026-04-05 · SEC EDGAR source
- “Our consolidated operating margins decreased from 10.9% to 10.7% in the first quarter of fiscal year 2026, as compared to the first quarter of fiscal year 2025, primarily due to gross margin headwinds and impact of the extra fiscal week, partially offset by productivity and cost containment initiatives.”
- “Tariffs enacted and currently in effect increased our cost of revenue by approximately $8 million for the three months ended April 5, 2026.”
- “Costs for significant environmental matters decreased expenses by $1.2 million for the three months ended March 30, 2025.”
- “Disposition of businesses and assets, net decreased expenses by $5.1 million for the three months ended April 5, 2026.”
Source pages
Exhibit sources
Research trail
Every number, checked
Every numeric or dated claim in this note was checked against our stored company data before publishing — each figure below links to the page it comes from.